Expert Q&A: Fostering Mental Health in the Lab
Laboratorian and workplace wellness expert discusses mental health challenges in the lab—and how to foster safety and support
Laboratorian and workplace wellness expert discusses mental health challenges in the lab—and how to foster safety and support
Recent study shows scores capable of assessing genetic risk of coronary artery disease can also ID those at high risk of death.
A recent study shows pharmacogenetic testing can help caregivers make better decisions when prescribing antidepressants.
The new CAP guidance addresses use of immune checkpoint inhibitors for evaluating and treating patients with specific cancers.
What the equity rule is, who it affects, and how to comply.
A recent study shows that most patients who underwent such screening were diagnosed at an earlier stage than those who did not.
A recent study shows that combined cardiomyopathy and arrhythmia genetic testing catches things disease-specific testing would miss.
For labs, the big takeaway is how prominently molecular testing and profiling figures in so many aspects of the NCCN’s recommendations.
New tool helps determine whether immunotherapy is a better option for patients than chemotherapy or radiotherapy.
New study shows that ctDNA liquid biopsy testing after stage II colon cancer may determine whether chemotherapy is required.
Inhalers and sensors that offer digital monitoring are beginning to gain FDA approval, and could solve usage issues of traditional products.